US 12280108
Vaccines having an antigen and interleukin-21 as an adjuvant
granted A61KA61K2039/53A61K2039/55527
Quick answer
US patent 12280108 (Vaccines having an antigen and interleukin-21 as an adjuvant) held by Inovio Pharmaceuticals, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/53, A61K2039/55527, A61K39/08, A61K39/12